Tech Innovator Profile – Verge Genomics
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Verge Genomics is an AI-driven biopharmaceutical drug discovery company which applies patient genomes, epigenomics, and gene expression for identifying novel effective drugs, stratify patient subpopulations, and therapeutic gene targets for accelerating clinical success.
Scope
The report provides information and insights into Verge Genomics's, including –
– Overview of the company and its product offering
– Detailed insight into its business model, company type and headquarter
– Information on funding
– Biography of top management
Reasons to Buy
– Gain insights into Verge’s business operations.
– Gain insights into funding and partnerships
– Gain understanding about its technology focus.
Datavant
Massachusetts General Institute for Neurodegenerative Disease
Motor Neuron Center at Columbia University
Keck School of Medicine
Two Sigma Ventures
Slow Ventures
Refactor Capital
OS Fund
Karlin Ventures
IA Ventures
Great Oaks Venture Capital
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.